As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business. | ...
DeepIntent has launched an agentic AI tool to help healthcare marketers more efficiently extract insights from databases ...
With the passage of another year in the biz, and another slate of company earnings stacked up against one another, Fierce is ...
U.S. pharmaceutical lobby group PhRMA has launched a new ad offensive that looks to highlight the American life sciences ...
The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) and the U.S. | The program looks to support ...
Merck & Co.’s first-in-class HIF-2 alpha inhibitor Welireg is touching down in the clear cell renal cell carcinoma (ccRCC) | ...
Following much opposition from drugmakers, Germany has scrapped its plan to install a program that would have reduced the ...
In patients with BTK-pretreated chronic lymphocytic leukemia (CLL), AbbVie and Roche’s Venclexta (venetoclax) is the drug to ...
Of the 400 million patients worldwide diagnosed with rare diseases, about 250 million of them live in North and Southeast Asia 1. That includes patients in major markets such as China and Japan, as ...
IQVIA Digital has developed technology to help pharma marketers identify nurse practitioners (NPs) and physician associates ...
Eisai snares government manufacturing grant as it brings Leqembi packaging to UK with $65M expansion
As the United Kingdom juggles industry concerns about the region’s waning appeal and competitiveness, Eisai is getting a lift from a production-tinged fund that the British government first unveiled ...
While patients in Novo trials don't need to take any action, the company recommends patients "remain vigilant and report to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results